In 2008, TCGA detailed a multi-dimensional analysis of 216 cases of GBM that identified genetic changes that include inactivation of the Neurofibromin 1 gene, ERRB2 mutations, and MGMT methylation (Cancer Genome Atlas Research Network, 2008). The gene discussed is MGMT; the disease is glioblastoma.